Skip to main content
. Author manuscript; available in PMC: 2020 Mar 1.
Published in final edited form as: J Neuroimmune Pharmacol. 2018 Jul 6;14(1):120–133. doi: 10.1007/s11481-018-9792-7

Table 2.

Description of cART regimens and HIV and HAND diagnoses

Study Participant HAND Diagnosis cART at Draw Regimen Base PI y/n Yr Dx Year Started Any ART Time From Diagnosis Time From Starting ART Time From Diagnosis to Starting ART
1 No Impairment Truvada (viread, emtriva), raltegravir INT no 1996 1996 16 16 0
2 MCMD epzicom (ziagen, epivir), rit darunavir, raltegravir PI, INT yes 1991 1992 21 20 1
3 No Impairment atripla (viread, emtriva, efavirenz) NNRTI no 1984 1988 28 24 4
4 MCMD epivir, abacavir, raltegravir INT no 1992 1997 20 15 5
5 HAD Epzicom (ziagen, epivir), atazanavir PI yes 1993 1998 19 14 5
6 ANI tenofovir, rit darunavir, raltegravir PI, INT yes 1992 1993 20 19 1
7 MCMD Epzicom (ziagen, epivir), efavirenz NNRTI no 1994 1996 18 16 2
8 HAD truvada (viread, emtriva), rit atazanavir PI yes 1991 2010 21 2 19
9 No Impairment truvada (viread, emtriva), rit darunavir PI yes 1993 1997 19 15 4
10 MCMD Truvada (viread, emtriva), raltegravir INT no 2002 2003 10 9 1
11 NPI-O non-compliant none no 1987 2010 25 2 23
12 NPI-O non-compliant none no 1985 1990 27 22 5
13 MCMD atripla (viread, emtriva, efavirenz) NNRTI no 1991 2003 21 9 12
14 NPI-O truvada (viread, emtriva), rit atazanavir PI yes 1985 2004 27 8 19
15 ANI epivir, abacavir, raltegravir INT no 1999 2000 14 13 1
16 MCMD abacavir, kaletra (rit lopinivir) PI yes 1990 1993 23 20 3
17 MCMD truvada (viread, emtriva), raltegravir, rit fosamprenavir PI, INT yes 1998 1999 15 14 1
18 No Impairment epivir, rit darunavir, raltegravir PI, INT yes 1990 2005 23 8 15
19 NPI-O epzicom (ziagen, epivir), rit darunavir PI yes 1997 2000 16 13 3
20 NPI-O Truvada (viread, emtriva), raltegravir INT no 2010 2011 3 2 1
21 HAD epzicom (ziagen, epivir), rit darunavir PI yes 1994 1997 19 16 3
22 No Impairment Truvada (viread, emtriva), raltegravir INT no 1991 1995 22 18 4
23 NPI-O combivir (azt, 3tc), kaletra (rit ritonivir), efavirenz PI, NNRTI yes 1985 2002 28 11 17
24 No Impairment complera (emtricitabine, tenofovir, rilpivirine), rit darunavir, raltegravir PI, INT, NNRTI yes 1986 1991 27 22 5
25 No Impairment atripla (viread, emtriva, efavirenz) NNRTI no 1999 1999 14 14 0
26 NPI-O truvada (viread, emtriva), abacavir, rit darunavir PI yes 1999 2003 14 10 4
27 NPI-O truvada (viread, emtriva), rit darunavir, raltegravir PI, INT yes 1998 1998 15 15 0
28 NPI-O Epzicom (ziagen, epivir), atazanavir PI yes 1985 1995 28 18 10
29 No Impairment non-compliant None no 1991 2008 22 5 17
30 No Impairment epivir, rit darunavir, raltegravir, maraviroc PI, INT, fusion yes 1988 1993 25 20 5
31 HAND / mcmd combivir (azt, 3tc), rit atazanavir PI yes 1989 1997 26 18 8
32 HAND / mcmd Complera (emtricitabine, tenofovir, rilpivirine) NNRTI no 1992 1994 23 21 2
33 HAND / mcmd 3tc. Abacavir, efavirenz NNRTI no 1989 2000 26 15 11
34 No Impairment emtricitabine, tenofovir, rit atazanavir PI yes
35 HAND / mcmd truvada (viread, emtriva), rit atazanavir PI yes 2000 2001 15 14 1
36 HAND / HAD truvada (viread, emtriva), raltegravir INT no 1999 2000 16 15 1
37 No Impairment emtricitabine, tenofovir, raltegravir INT no
38 HAND / HAD Complera (emtricitabine, tenofovir, rilpivirine), dolutegravir NNRTI, INT no 1994 2015 21 0 21
39 NPI-O tenofovir, triumeq (abacavir, dolutegravir, 3tc) INT no 1990 1997 25 18 7
40 No Impairment truvada (viread, emtriva), rit atazanavir PI yes 2000 2000 15 15 0
41 No Impairment truvada (viread, emtriva), rit atazanavir, raltegravir PI, INT yes 1992 1992 23 23 0
42 No Impairment epivir, rit darunavir, etravirine, raltegravir PI, NNTRI, INT yes 1991 1997 24 18 6
43 HAND / MCMD truvada (viread, emtriva), kaletra (rit lopinivir) PI yes 1985 2000 30 15 15
44 HAND / ANI Epzicom (ziagen, epivir), dolutegravir INT no 1999 2000 16 15 1
45 HAND / HAD epzicom (ziagen, epivir), rit atazanavir PI yes 1990 1997 25 18 7